Farallon Capital Management LLC Lian Bio Transaction History

Farallon Capital Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$2.15 - $6.01 $215,000 - $601,000	-100,000 Reduced 16.67%	500,000 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$6.14 - $16.2 $3.68 Million - $9.72 Million	600,000 New	600,000 $3.7 Million

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.